Seguimiento farmacoterapéutico a pacientes embarazadas con infección del tracto urinario

Abstract

Introduction: This research study exposes the difficulty involved in monitoring and controlling drug therapy in pregnant women suffering from urinary tract infection (UTI). Theoretical information was collected to support the importance of adequate monitoring, using optimal knowledge and efficient methods, such as the approach developed by dáder, with the aim of improving pregnant women’s health. Objective: The aim of this study was to assess the follow-up of drug therapy in pregnant women suffering from Urinary Tract Infection in order to detect possible drug-related problems (DRP). Methodology: A methodology based on a descriptive bibliographic analysis was applied. An exhaustive search, compilation, and selection of current information available in several open-access scientific databases was carried out with the aim of examining the pharmacotherapeutic scope in pregnant women with UTI. Results: The results of the analyzed articles were able to show several aspects, of which the main drug-related problem was DRP 1 at 22.5%. Conclusion: It could be concluded that the main drug-related problem was the necessity of DRP 1 with Amox/ac-clavulanic acid, the drug causing an adverse reaction in most cases.